Free public webinar series presented by leading medicines policy researchers. The webinars aim to make recent, policy-relevant research more accessible to a global public audience and facilitate flows of knowledge between the research and policy & practice communities.




Past webinars (recordings and materials available on links)

Dec 2021 | Joseph Larsen, Venatorx Pharmaceuticals; Former BARDA; Daniel P. Gross, Duke University Fuqua School of Business, and National Bureau of Economic Research

Nov 2021 | Donald W. Light, Professor of comparative health policy and psychiatry, School of Osteopathic Medicine, Rowan University, Stratford; Adjunct professor in medical ethics, New York University

Oct 2021 Gabriela Costa Chaves, Independent Researcher; Pauline Londeix, Observatoire de la Transparence dans les Politiques du Médicament (OTMeds)

June 2021 Eduardo Urias, Assistant Professor, Faculty of Science, Athena Institute, VU University Amsterdam; Danielle Navarro, Research Assistant, Global Health Centre

April 2021 | Manica Balasegaram, Executive Director, GARDP - Global Antibiotic Research and Development Partnership; Michelle Childs, Director of Policy Advocacy, DNDi - Drugs for Neglected Diseases initiative


March 2021 | Marcela Vieira, Researcher and Project Coordinator of the Knowledge Network for Innovation and Access to Medicines, Global Health Centre, IHEID

February 2021 | Monirul Azam, Associate professor in Law, Södertörn University and Adjunct faculty in Intellectual Property Law, Stockholm University; Sangeeta Shashikant, Development and Intellectual Property, Third World Network



November 2020 | Ayesha Sitlani, Associate Vice President - Antibody Strategy, International AIDS Vaccine Initiative (IAVI)


October 2020 | Julia Barnes-Weise, The Global Health Innovation Alliance Accelerator (GHIAA); Viviana Galli, European Alliance for Responsible R&D and Affordable Medicines



September 2020 | David Levine, Elon University School of Law

June 2020 | Julia Paranhos, Federal University of Rio de Janeiro; Ellen 't Hoen, Medicines Law & Policy


April 2020 | Yousuf Vawda, University of KwaZulu-Natal; Lynette Mabote, Southern African Programme on Access to Medicines and Diagnostics (SAPAM)

March 2020 | Dzintars Gotham, Independent researcher; Lindsay McKenna, Treatment Action Group (TAG)

February 2020 | Suerie Moon, Global Health Centre, Graduate Institute of Geneva; Tania Cernuschi, World Health Organization


December 2019 | Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board (PMPRB), Canada


November 2019 | Slavek Roller, Faculty of Economics and Business, Goethe University Frankfurt; Nadya Wells, Global Health Centre, Graduate Institute of Geneva


October 2019 | Peter Yu, Center for Law and Intellectual Property at Texas A&M University; Yuanqiong Hu, Access Campaign of Médecins Sans Frontières (MSF)


September 2019 | Reed Beall, University of Calgary; Mayra Vasquez,  National College of Pharmaceutical Chemists of Colombia; Miguel Cortes,  UNOPS (United Nations Office for Project Services)


June 2019 | Marg Ewen and Molly Lepeska, Health Action International

April 2019 | Ekaterina Cleary, Bentley University

March 2019 | Kiu Tay-Teo, World Health Organization

February 2019 | Carolina Gomez, INVIMA - Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Colombia’s National Institute of Food and Drug Monitoring)

January 2019 | Fred Abbott, Florida State University College of Law

December 2018 | Sabine Vogler, Austrian Public Health Institute (GÖG)

November 2018 | Gavin Yamey, Duke University

October 2018 | Achal Prabhala, accessibsa: Innovation & Access to Medicines in India, Brazil & South Africa

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.